These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2841895)

  • 21. Primary thymic carcinomas.
    Wick MR; Scheithauer BW; Weiland LH; Bernatz PE
    Am J Surg Pathol; 1982 Oct; 6(7):613-30. PubMed ID: 6295194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic neuroendocrine tumor of unknown primary presenting as acute pancreatitis.
    Dhar S; Grossman CE; Kokroo T
    Am J Med Sci; 2008 Apr; 335(4):304-6. PubMed ID: 18414070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of etoposide in the treatment of poorly differentiated carcinoma of unknown primary site.
    Hainsworth JD; Johnson DH; Greco FA
    Cancer; 1991 Jan; 67(1 Suppl):310-4. PubMed ID: 1984833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 25. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon.
    Xu B; Scognamiglio T; Cohen PR; Prasad ML; Hasanovic A; Tuttle RM; Katabi N; Ghossein RA
    Hum Pathol; 2017 Jul; 65():133-139. PubMed ID: 28552827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
    Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
    Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
    Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy.
    Hisamori S; Okabe H; Yoshizawa A; Sakai Y
    Int J Clin Oncol; 2010 Oct; 15(5):493-6. PubMed ID: 20224882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastasis of unknown origin.
    Haskell CM; Cochran AJ; Barsky SH; Steckel RJ
    Curr Probl Cancer; 1988; 12(1):5-58. PubMed ID: 3067982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electron microscopy of needle biopsies from cancer patients with unknown primary tumors].
    Horn T; Andersen CB; Nerstrøm H
    Ugeskr Laeger; 1993 Apr; 155(15):1126-9. PubMed ID: 8488599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Unknown primary cancer].
    Furue H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small cell carcinoma of unknown primary.
    Lobins R; Floyd J
    Semin Oncol; 2007 Feb; 34(1):39-42. PubMed ID: 17270664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer of unknown primary: clinicopathologic correlations.
    Blaszyk H; Hartmann A; Bjornsson J
    APMIS; 2003 Dec; 111(12):1089-94. PubMed ID: 14678017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
    Lenzi R; Hess KR; Abbruzzese MC; Raber MN; Ordoñez NG; Abbruzzese JL
    J Clin Oncol; 1997 May; 15(5):2056-66. PubMed ID: 9164218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patients with cancer of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
    Hainsworth JD; Spigel DR; Litchy S; Greco FA
    J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.